VTYX Ventyx Biosciences Inc.: Accounting Value per Share

Graphic logo of Ventyx Biosciences (VTYX)

Ventyx Biosciences (VTYX) price action reflects the development of its immune-drug business, where reliable molecule logistics for testing and a hub network ensure stable profits, with the current figure standing at 2.69. Growth is driven by the development of selective TYK2 inhibitors, which increase the likelihood of an acquisition by industry behemoths. Meanwhile, the company must prove the superiority of its oral agents to withstand pressure from powerful market opponents.

Ventyx Biosciences Inc. (VTYX): Share Book Value from 07/04/2022 to 03/14/2026

ventyxbio.com - analytical breakdowns and key metrics (VTYX)

- price and consensus price forecast:
Stock Quotes Ventyx Bio|VTYX - Average Forecast Price
- market capitalization data:
Market Valuation Ventyx Biosciences, Inc.|VTYX - Business Value
- book capitalization data:
Net Assets per Single Share Ventyx Biosciences|VTYX - Net Asset Value|Market Capitalization to Book Value Ratio ventyxbio.com|VTYX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Ventyx Biosciences|VTYX - Long-Term Debt to Capital|Short-Term Debt to Equity Ventyx Biosciences, Inc.|VTYX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Ventyx Biosciences, Inc.
Fundamental company valuation:Ventyx Bio - VTYX
Manufactured products of Ventyx Biosciences, Inc.

Book value per share reflects the portion of equity attributable to a single security by dividing the difference between total assets and liabilities by the number of shares outstanding. By analyzing changes in BVPS, an investor can assess the risk of equity dilution and the impact of Ventyx Biosciences (VTYX) strategic alliances with clinics on the capitalization of intellectual assets during the development of anti-inflammatory molecules.

Competitors of Ventyx Biosciences (VTYX)

ARGX (Argenx) - Accounting Value per Share|BioNTech Pharma (BNTX) - Net Asset Value per Share|Accounting Value per Share Abivax Corp|ADMA (admabiologics.com) - Equity per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|ANAB - Net Asset Value per Share|ATXS - Accounting Value per Share|ENGN - Net Assets per Single Share|Book Value per Share RAPT|JBIO (Aerovate Therapeutics) - Net Asset Value per Share|Net Assets per Single Share Aclaris Therapeutics, Inc. (ACRS)|Equity per Share Kyverna Therapeutics Inc. (KYTX)|Accounting Value per Share Tiziana Life Sciences PLC|Book Price of a Share Cabaletta Bio Inc CABA|THTX: Accounting Value per Share|AVTX - Net Asset Value per Share|Eledon Pharmaceuticals, Inc. (ELDN) - Accounting Value per Share|Agenus, Inc. (AGEN) - Equity per Share|Accounting Value per Share Climb Bio, Inc. CLYM|Zura Bio Ltd (ZURA) - Accounting Value of a Share|Book Value per Share aTyr Pharma, Inc.|Net Assets per Single Share Adagene Corp|IMA (ImageneBio Inc) - Book Value per Share|Net Assets per Share STTK (shattucklabs.com)|EQ: Net Assets per Single Share|Connect Biopharma Holdings - Net Asset Value per Share|Net Assets per Single Share IMUX (Immunic Inc)|ATRA - Net Assets per Share|IFRX (inflarx.de) - Book Value per Share|X4 Pharmaceuticals Inc. (XFOR) - Accounting Value per Share|ACET: Book Value per Share|Net Assets per Share Celularity Corp|INmune Bio, Inc. - Book Value per Share|Net Asset Value per Share BRNS (barinthusbio.com)|KZR - Net Assets per Single Share|Equity per Share SAB Biotherapeutics Inc. SABS|AKTX: Book Value per Share|ENLV - Accounting Value per Share|Book Value per Share QTTB|GOVX (geovax.com) - Net Asset Value per Share|EDSA: Net Assets per Single Share|Net Assets per Share iBio Inc (IBIO)|Accounting Value per Share Carisma Therapeutics (CARM)|Net Assets per Single Share XTL Bio XTLB|Accounting Value per Share Bolt Biotherapeutics, Inc. (BOLT)|HCWB - Book Price of a Share|APVO (Aptevo) - Accounting Value per Share|AIM ImmunoTech, Inc. (AIM) - Net Asset Value per Share|Accounting Value per Share aditxt.com|GRI (GRI Bio Corporation) - Equity per Share|Net Assets per Single Share XORTX Therapeutics Inc. XRTX|Share Book Value reshapelifesciences.com|Revelation Biosciences, Inc. (REVB) - Book Value per Share|Accounting Value of a Share Indaptus Therapeutics Inc (INDP)|Book Value per Share SCNI (Scinai)|CalciMedica Inc - Book Value per Share|Net Assets per Single Share Affimed Therapeutics (AFMD)|ALLK: Accounting Value of a Share|HOOK (hookipapharma.com) - Net Assets per Single Share|IGM Biosciences (IGMS) - Accounting Value per Share|ITOS (iTeos) - Book Value per Share|Book Value per Share Ocean Biomedical Corp (OCEA)|TC Biopharm (TCBP) - Accounting Value per Share|Accounting Value of a Share thirdharmonicbio.com (THRD)